Thursday, Somanetics Corp. (SMTS) reported a decline in third-quarter net income to $2.23 million or $0.17 per share from $3.05 million or $0.23 per share in the prior year period. On average, 6 analysts polled by Thomson Reuters expected earnings per share of $0.14. Analysts' estimate typically excludes one-time items.
Net revenues for the third quarter increased to $12.51 million from $12.37 million in the year earlier period. Four analysts estimated revenues of $13.09 million for the quarter.
Somanetics signed a three-year extension of its exclusive distribution agreement with Covidien for Europe, the Middle East and Africa.
Somanetics reiterated its fiscal 2009 net revenues guidance, expecting it to lie between $50 million and $52 million. Fiscal 2009 income before income taxes are still expected to be in the range of $11.2 million to $11.6 million. Four analysts estimate revenues of $50.60 million for fiscal 2009.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.